300149 睿智医药
已收盘 08-12 15:00:00
资讯
新帖
简况
8月11日睿智医药涨5.63%，银河康乐股票A基金重仓该股
证券之星 · 08-11 16:38
8月11日睿智医药涨5.63%，银河康乐股票A基金重仓该股
睿智医药：不涉及医药商业（流通/分销）业务
证券之星 · 08-11 11:36
睿智医药：不涉及医药商业（流通/分销）业务
睿智医药：公司长期服务于国内外大中型制药企业及生物技术公司
证券之星 · 08-11 11:36
睿智医药：公司长期服务于国内外大中型制药企业及生物技术公司
8月7日睿智医药涨7.53%，银河康乐股票A基金重仓该股
证券之星 · 08-07
8月7日睿智医药涨7.53%，银河康乐股票A基金重仓该股
睿智医药（300149）披露控股股东及其一致行动人持股比例被动稀释触及1%整数倍公告，8月5日股价上涨1.89%
证券之星 · 08-05
睿智医药（300149）披露控股股东及其一致行动人持股比例被动稀释触及1%整数倍公告，8月5日股价上涨1.89%
股市必读：睿智医药新发布《关于2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》
证券之星 · 08-05
股市必读：睿智医药新发布《关于2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》
睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，8月3日股价上涨1.79%
证券之星 · 08-03
睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，8月3日股价上涨1.79%
睿智医药（300149）披露董事会秘书取得任职培训证明并正式履职公告，7月30日股价下跌3.8%
证券之星 · 07-30
睿智医药（300149）披露董事会秘书取得任职培训证明并正式履职公告，7月30日股价下跌3.8%
睿智医药(300149)7月10日股东户数3.98万户，较上期减少4.86%
证券之星 · 07-27
睿智医药(300149)7月10日股东户数3.98万户，较上期减少4.86%
7月27日睿智医药涨9.24%，银河康乐股票A基金重仓该股
证券之星 · 07-27
7月27日睿智医药涨9.24%，银河康乐股票A基金重仓该股
7月24日睿智医药跌10.56%，银河康乐股票A基金重仓该股
证券之星 · 07-24
7月24日睿智医药跌10.56%，银河康乐股票A基金重仓该股
睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就公告，7月22日股价上涨1.44%
证券之星 · 07-22
睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就公告，7月22日股价上涨1.44%
睿智医药（300149）披露股票交易异常波动公告，7月16日股价上涨6.74%
证券之星 · 07-16
睿智医药（300149）披露股票交易异常波动公告，7月16日股价上涨6.74%
7月15日睿智医药（300149）龙虎榜数据：机构净买入373.11万元，北向资金净买入2670.95万元
证券之星 · 07-15
7月15日睿智医药（300149）龙虎榜数据：机构净买入373.11万元，北向资金净买入2670.95万元
半年BD狂飙千亿、龙头预增13倍！创新药涨停潮再起
格隆汇 · 07-15
半年BD狂飙千亿、龙头预增13倍！创新药涨停潮再起
CRO板块领涨，睿智医药20CM涨停
北京商报 · 07-15
CRO板块领涨，睿智医药20CM涨停
睿智医药(300149)6月30日股东户数4.18万户，较上期增加20.31%
证券之星 · 07-13
睿智医药(300149)6月30日股东户数4.18万户，较上期增加20.31%
睿智医药(300149)6月30日股东户数4.18万户，较上期增加20.31%
证券之星 · 07-06
睿智医药(300149)6月30日股东户数4.18万户，较上期增加20.31%
睿智医药（300149）披露向特定对象发行股票获深交所审核通过公告，7月2日股价下跌4.44%
证券之星 · 07-02
睿智医药（300149）披露向特定对象发行股票获深交所审核通过公告，7月2日股价下跌4.44%
6月23日睿智医药（300149）龙虎榜数据：机构净卖出89.55万元，北向资金净卖出631.78万元
证券之星 · 06-23
6月23日睿智医药（300149）龙虎榜数据：机构净卖出89.55万元，北向资金净卖出631.78万元
加载更多
公司概况
公司名称：
睿智医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2010-12-22
主营业务：
睿智医药科技股份有限公司的主营业务是提供涵盖化学药研发以及生物药从早期发现到开发与规模化生产阶段的一体化服务。公司的主要产品是化学业务、药效药动业务、大分子业务。
发行价格：
28.00
{"stockData":{"symbol":"300149","market":"SZ","secType":"STK","nameCN":"睿智医药","latestPrice":10.8,"timestamp":1786518183000,"preClose":11.07,"halted":0,"volume":57068359,"delay":0,"changeRate":-0.0244,"floatShares":482000000,"shares":505000000,"eps":-0.0226,"marketStatus":"已收盘","change":-0.27,"latestTime":"08-12 15:00:00","open":10.72,"high":11.41,"low":10.72,"amount":628000000,"amplitude":0.0623,"askPrice":10.81,"askSize":117,"bidPrice":10.8,"bidSize":1281,"shortable":0,"etf":0,"ttmEps":-0.0226,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786584600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.07,"symbolType":"stock","openAndCloseTimeList":[[1786498200000,1786505400000],[1786510800000,1786518000000]],"highLimit":12.18,"lowLimit":9.96,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":504985807,"isCdr":false,"pbRate":4.36,"roa":"--","roe":"--","epsLYR":0.03,"committee":0.111402,"marketValue":5454000000,"turnoverRate":0.1185,"status":1,"floatMarketCap":5201000000},"requestUrl":"/m/hq/s/300149","defaultTab":"news","newsList":[{"id":"2658864995","title":"8月11日睿智医药涨5.63%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658864995","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658864995?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:38","pubTimestamp":1786437525,"startTime":"0","endTime":"0","summary":"证券之星消息，8月11日睿智医药涨5.63%创60日新高，收盘报11.07元，换手率17.1%，成交量82.33万手，成交额9.01亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100026182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969934","title":"睿智医药：不涉及医药商业（流通/分销）业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969934?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:36","pubTimestamp":1786419389,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司在医药商业领域是否有布局？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。公司核心业务为医药研发及生产服务（CRO/CDMO），为国内外大中型制药企业、生物技术公司及科研院校提供涵盖化学药研发以及生物药从早期发现到开发与规模化生产阶段的一体化服务，不涉及医药商业（流通/分销）业务。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100014874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","159938","300149","BK1515","BK0216","09939","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969980","title":"睿智医药：公司长期服务于国内外大中型制药企业及生物技术公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969980?lang=zh_cn&edition=full","pubTime":"2026-08-11 11:36","pubTimestamp":1786419380,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问今年2026年国内外CRO服务订单能不能大幅提升？今年新签多少家国内外客户？公司和国内外哪些大型药企进行合作？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。关于公司业务进展及经营情况，请关注公司定期报告；关于合作客户信息，公司长期服务于国内外大中型制药企业及生物技术公司，具体客户名单及合作细节涉及商业保密协议约定，不便披露，敬请谅解。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100014861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","01477","BK0216","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657169106","title":"8月7日睿智医药涨7.53%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657169106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657169106?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:47","pubTimestamp":1786092474,"startTime":"0","endTime":"0","summary":"证券之星消息，8月7日睿智医药涨7.53%，收盘报10.42元，换手率15.78%，成交量76.0万手，成交额7.68亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657523552","title":"睿智医药（300149）披露控股股东及其一致行动人持股比例被动稀释触及1%整数倍公告，8月5日股价上涨1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657523552","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657523552?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:26","pubTimestamp":1785939978,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，睿智医药报收于9.7元，较前一交易日上涨1.89%，最新总市值为48.98亿元。公司于近日披露《关于控股股东、实际控制人及其一致行动人持股比例被动稀释触及1%整数倍的公告》。控股股东、实际控制人WOO SWEE LIAN先生及其一致行动人睿联投资、MEGA STAR、郑文略合计持股数量未变，合计持股比例由21.1811%被动稀释至20.8866%，被动稀释触及1%整数倍。本次权益变动不涉及股份减持，不触及要约收购，未导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500043550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657035565","title":"股市必读：睿智医药新发布《关于2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657035565","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657035565?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:23","pubTimestamp":1785871421,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，睿智医药报收于9.52元，上涨4.5%，换手率9.65%，成交量45.78万手，成交额4.39亿元。当日关注点交易信息汇总：8月4日主力资金净流出39.03万元，游资资金净流入1396.51万元。公司公告汇总：8月5日完成2025年限制性股票激励计划首次授予部分第一个归属期登记，归属股份702.1815万股，总股本增至504,985,807股，控股股东及其一致行动人持股比例被动稀释至20.89%。股票来源为公司向激励对象定向发行A股普通股，不另设禁售期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500003829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656377113","title":"睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，8月3日股价上涨1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656377113","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656377113?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:38","pubTimestamp":1785767899,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，睿智医药报收于9.11元，较前一交易日上涨1.79%，最新总市值为45.36亿元。该股当日开盘8.98元，最高9.13元，最低8.83元，成交额达1.78亿元，换手率为4.16%。公告显示，公司于2026年8月5日完成2025年限制性股票激励计划首次授予部分第一个归属期的股份归属登记，本次归属日为2026年8月5日，归属股票数量为702.1815万股，归属对象共计107人。本次归属后公司总股本增至504,985,807股，控股股东及其一致行动人持股比例被动稀释至20.89%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655784805","title":"睿智医药（300149）披露董事会秘书取得任职培训证明并正式履职公告，7月30日股价下跌3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655784805","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655784805?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:23","pubTimestamp":1785421395,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，睿智医药报收于8.6元，较前一交易日下跌3.8%，最新总市值为42.82亿元。公告显示，公司于2026年5月18日聘任吴文华先生为董事会秘书，因其当时尚未取得深圳证券交易所董事会秘书培训证明，暂由董事长代行职责。截至公告披露日，吴文华先生已通过培训并取得《上市公司董事会秘书培训证明》，自取得证明之日起正式履行董事会秘书职责。公司董事会确认董事长代行职责时间未超过九个月，符合相关监管要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000039746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016610","title":"睿智医药(300149)7月10日股东户数3.98万户，较上期减少4.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654016610?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:36","pubTimestamp":1785144967,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年7月10日公司股东户数为3.98万户，较6月30日减少2034.0户，减幅为4.86%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至7月10日，医疗服务行业平均股东户数为4.91万户。从股价来看，2026年6月30日至2026年7月10日，睿智医药区间跌幅为6.18%，在此期间股东户数减少2034.0户，减幅为4.86%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700022897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654201311","title":"7月27日睿智医药涨9.24%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654201311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654201311?lang=zh_cn&edition=full","pubTime":"2026-07-27 16:48","pubTimestamp":1785142134,"startTime":"0","endTime":"0","summary":"证券之星消息，7月27日睿智医药涨9.24%，收盘报9.34元，换手率11.32%，成交量53.71万手，成交额4.93亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700021167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653700187","title":"7月24日睿智医药跌10.56%，银河康乐股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653700187","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653700187?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:51","pubTimestamp":1784883076,"startTime":"0","endTime":"0","summary":"证券之星消息，7月24日睿智医药跌10.56%，收盘报8.55元，换手率11.37%，成交量53.95万手，成交额4.84亿元。重仓睿智医药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为银河基金的银河康乐股票A。银河康乐股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400028932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653765721","title":"睿智医药（300149）披露2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就公告，7月22日股价上涨1.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653765721","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653765721?lang=zh_cn&edition=full","pubTime":"2026-07-22 22:17","pubTimestamp":1784729837,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，睿智医药报收于9.88元，较前一交易日上涨1.44%，最新总市值为49.2亿元。该股当日开盘9.35元，最高10.24元，最低9.3元，成交额达6.12亿元，换手率为13.01%。睿智医药于近日披露《关于2025年限制性股票激励计划首次授予部分第一个归属期归属条件成就的公告》。本次符合归属条件的激励对象共107人，归属数量为702.1815万股，股票来源为公司向激励对象定向发行A股普通股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200047366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651176440","title":"睿智医药（300149）披露股票交易异常波动公告，7月16日股价上涨6.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651176440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651176440?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:12","pubTimestamp":1784211137,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，睿智医药报收于11.09元，较前一交易日上涨6.74%，最新总市值为55.22亿元。该股当日开盘10.17元，最高11.4元，最低10.1元，成交额达13.99亿元，换手率为27.21%。公司于2026年7月16日发布《股票交易异常波动公告》称，睿智医药科技股份有限公司股票连续两个交易日收盘价格涨幅偏离值累计超过30%，构成股票交易异常波动。公司将于2026年8月29日披露2026年半年度报告，目前编制工作正常进行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600040074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651560274","title":"7月15日睿智医药（300149）龙虎榜数据：机构净买入373.11万元，北向资金净买入2670.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651560274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651560274?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:28","pubTimestamp":1784107697,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月15日公布的交易公开信息显示，睿智医药因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月15日收盘，睿智医药报收于10.39元，上涨19.98%，涨停，换手率15.58%，成交量73.96万手，成交额7.5亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入373.11万元，北向资金合计净买入2670.95万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033360.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651879434","title":"半年BD狂飙千亿、龙头预增13倍！创新药涨停潮再起","url":"https://stock-news.laohu8.com/highlight/detail?id=2651879434","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651879434?lang=zh_cn&edition=full","pubTime":"2026-07-15 13:50","pubTimestamp":1784094601,"startTime":"0","endTime":"0","summary":"政策密集加码","market":"us","thumbnail":"https://img3.gelonghui.com/9d73a-d7eab21c-e179-4850-9c4c-edf64e1fd8eb.jpg?guru_height=716&guru_width=1280&guru_size=127989","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/9d73a-d7eab21c-e179-4850-9c4c-edf64e1fd8eb.jpg?guru_height=716&guru_width=1280&guru_size=127989"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5584162","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BD","BK0146","BK0070","BK0188","300149","MEDX","BK0028","06978","BK0077","BK0216","000566","BK1574","BK0012","BK0060","002940","600664","002317","IBBQ","159992","BK1161","BK0239","688192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651433781","title":"CRO板块领涨，睿智医药20CM涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2651433781","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651433781?lang=zh_cn&edition=full","pubTime":"2026-07-15 10:24","pubTimestamp":1784082273,"startTime":"0","endTime":"0","summary":"7月15日，CRO板块领涨A股，板块内个股全线飘红，其中，睿智医药（300149）20CM涨停。交易行情显示，睿智医药早盘高开1.04%，随后快速拉升，并最终封上涨停。截至北京商报记者发稿，睿智医药收于10.39元/股，涨幅19.98%。此外，昭衍新药、百花医药亦封上涨停，万邦医药等、奥浦迈等个股涨幅超10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153807104487.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807104487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651036190","title":"睿智医药(300149)6月30日股东户数4.18万户，较上期增加20.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651036190","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651036190?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:51","pubTimestamp":1783936299,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年6月30日公司股东户数为4.18万户，较6月10日增加7061.0户，增幅为20.31%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.85万户。从股价来看，2026年6月10日至2026年6月30日，睿智医药区间涨幅为21.68%，在此期间股东户数增加7061.0户，增幅为20.31%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300026898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649964026","title":"睿智医药(300149)6月30日股东户数4.18万户，较上期增加20.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649964026","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649964026?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:36","pubTimestamp":1783330593,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年6月30日公司股东户数为4.18万户，较6月10日增加7061.0户，增幅为20.31%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至6月30日，医疗服务行业平均股东户数为4.85万户。从股价来看，2026年6月10日至2026年6月30日，睿智医药区间涨幅为21.68%，在此期间股东户数增加7061.0户，增幅为20.31%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600024615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648757505","title":"睿智医药（300149）披露向特定对象发行股票获深交所审核通过公告，7月2日股价下跌4.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648757505","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648757505?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:38","pubTimestamp":1782985121,"startTime":"0","endTime":"0","summary":"近日，睿智医药科技股份有限公司披露《关于向特定对象发行股票申请获得深圳证券交易所上市审核中心审核通过的公告》。公告显示，公司于2026年7月1日收到深圳证券交易所上市审核中心出具的《关于睿智医药科技股份有限公司申请向特定对象发行股票的审核中心意见告知函》，深交所认为公司符合发行条件、上市条件和信息披露要求。后续深交所将按规定报中国证监会履行注册程序。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200029678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645887889","title":"6月23日睿智医药（300149）龙虎榜数据：机构净卖出89.55万元，北向资金净卖出631.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645887889","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645887889?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:48","pubTimestamp":1782208127,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年6月23日公布的交易公开信息显示，睿智医药因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年6月23日收盘，睿智医药报收于9.14元，上涨19.95%，涨停，换手率7.94%，成交量37.69万手，成交额3.3亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出89.55万元，北向资金合计净卖出631.78万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300030843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786574578569,"stockEarnings":[{"period":"1week","weight":0.1134},{"period":"1month","weight":0.25},{"period":"3month","weight":0.1333},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.1449},{"period":"ytd","weight":0.1297}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"睿智医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"39800人(较上一季度减少4.86%)","perCapita":"12100股","listingDate":"2010-12-22","address":"广东省江门市江海区胜利南路164号","registeredCapital":"50498万元","survey":" 睿智医药科技股份有限公司的主营业务是提供涵盖化学药研发以及生物药从早期发现到开发与规模化生产阶段的一体化服务。公司的主要产品是化学业务、药效药动业务、大分子业务。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿智医药,300149,睿智医药股票,睿智医药股票老虎,睿智医药股票老虎国际,睿智医药行情,睿智医药股票行情,睿智医药股价,睿智医药股市,睿智医药股票价格,睿智医药股票交易,睿智医药股票购买,睿智医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}